|
Market Closed -
Euronext Paris
19:55:00 13/02/2026 +03
|
5-day change
|
1st Jan Change
|
|
154.70 EUR
|
+4.81%
|
 |
+13.67%
|
+30.00%
|
|
02-13 |
Genfit to Receive $20 Million Milestone Payment Linked to Sales of Ipsen's Iqirvo
|
MT
| |
02-13 |
Ipsen Remains in the Green with UBS Support
|  | |
02-13 |
Genfit Receives Milestone Payment from Ipsen for Iqirvo
| | |
02-12 |
Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook
|  | |
02-12 |
Ipsen S.A., 2025 Earnings Call, Feb 12, 2026
| | |
02-12 |
Ipsen S.A. Provides Earnings Guidance for the Full Year 2026
|
CI
| |
02-12 |
Ipsen Surges After Strong 2025 Results and Ambitious Targets
| | |
02-12 |
New Historic Record for the CAC 40 at Opening, Fresh Wave of Earnings Results
| | |
02-12 |
Ipsen : FY 2025 – Presentation (1.44 MB)
|
PU
| |
02-12 |
Carrefour, EssilorLuxottica, Hermès, Michelin, Rexel... Key Stocks to Watch Today in Paris
| | |
02-12 |
European Markets Expected to Rise, Corporate Earnings to Set the Pace for the Session
| | |
02-12 |
To Watch Today
| | |
02-12 |
Ipsen Increases Annual Net Profit by 28%
| | |
02-12 |
Ipsen : FY 2025 – Highlights (340.30 KB)
|
PU
| |
02-12 |
Ipsen FY revenue EUR 3,675.9 million
|
RE
| |
02-12 |
Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
|
GL
| |
02-12 |
Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
|
AQ
| |
02-12 |
Ipsen S.A. Reports Earnings Results for the Full Year Ended December 31, 2025
|
CI
| |
02-09 |
Zonebourse Corporate Earnings Calendar: Week of February 9 to 13, 2026
| | |
02-04 |
Pyxis Oncology, Inc. Announces Chief Executive Officer Changes, Effective February 3, 2026
|
CI
| |
02-03 |
Ipsen Sa Appoints Pierrick Lefranc as Executive Vice President and Member of the Executive Leadership Team, Effective April 1, 2026
|
CI
| |
01-30 |
Ipsen : expands pre-clinical pipeline in rare neurodegenerative diseases
|
PU
| |
01-29 |
Ipsen Nominates Peter Guenter to its Board of Directors, Effective January 28, 2026
|
CI
| |
01-29 |
Peter Guenter Appointed to Ipsen's Board of Directors
| | |
01-29 |
Ipsen nominates Peter Guenter to its Board of Directors
|
GL
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
